Our data showed that the expression of Bcl-2, Bcl-xL, Notch-1, and survivin proteins was significantly induced in response to CXCL12 treatment of pancreatic cancer cells (Figure 5B). The gene discussed is BCL2L1; the disease is pancreatic neoplasm.